(Q46921303)

26 December 2017

title

Is it time for spironolactone therapy in dialysis patients? (English)

1 reference

26 December 2017

0 references

1

Adrian Covic

1 reference

26 December 2017

2

Paul Gusbeth-Tatomir

1 reference

26 December 2017

author name string

David J A Goldsmith

series ordinal

3

1 reference

26 December 2017

language of work or name

English

0 references

publication date

31 January 2006

1 reference

26 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

26 December 2017

volume

21

1 reference

26 December 2017

issue

4

1 reference

26 December 2017

page(s)

854-858

1 reference

26 December 2017

The pathophysiology of aldosterone in the cardiovascular system

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Regression of existing glomerulosclerosis by inhibition of aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Inadequate treatment of cardiovascular disease and cardiovascular disease risk factors in dialysis patients: a commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Pharmacokinetics of eplerenone after single and multiple dosing in subjects with and without renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Review of aldosterone- and angiotensin II-induced target organ damage and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Aldosterone in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Arterial stiffness in renal patients: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Aldosterone and potassium balance in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Impact of the initial levels of laboratory variables on survival in chronic dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Cardiac arrest and sudden death in dialysis units

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Is spironolactone safe for dialysis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Safety of low-dose spironolactone administration in chronic haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Aldactone therapy in a peritoneal dialysis patient with decreased left ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Aldactone therapy in a peritoneal dialysis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

Aldactone therapy in a peritoneal dialysis patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK086

21 January 2018

Identifiers

DOI

10.1093/NDT/GFK086

1 reference

26 December 2017

1 reference

26 December 2017